Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

736 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial.
Ravassa S, López B, Ferreira JP, Girerd N, Bozec E, Pellicori P, Mariottoni B, Cosmi F, Hazebroek M, Verdonschot JAJ, Cuthbert J, Petutschnigg J, Moreno MU, Heymans S, Staessen JA, Pieske B, Edelmann F, Clark AL, Cleland JGF, Zannad F, Díez J, González A; HOMAGE Trial Committees and Investigators. Ravassa S, et al. Among authors: clark al. Eur J Heart Fail. 2022 Feb;24(2):321-331. doi: 10.1002/ejhf.2394. Epub 2021 Dec 9. Eur J Heart Fail. 2022. PMID: 34841615 Free article. Clinical Trial.
Insulin resistance in chronic heart failure.
Swan JW, Walton C, Godsland IF, Clark AL, Coats AJ, Oliver MF. Swan JW, et al. Among authors: clark al. Eur Heart J. 1994 Nov;15(11):1528-32. doi: 10.1093/oxfordjournals.eurheartj.a060425. Eur Heart J. 1994. PMID: 7835369
Leptin and cardiac cachexia: marker or mediator?
Cleland JG, Clark AL. Cleland JG, et al. Among authors: clark al. Eur Heart J. 1998 Oct;19(10):1421-2. Eur Heart J. 1998. PMID: 9820983 Review. No abstract available.
Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT.
Thackray S, Witte K, Clark AL, Cleland JG. Thackray S, et al. Among authors: clark al. Eur J Heart Fail. 2000 Jun;2(2):209-12. doi: 10.1016/s1388-9842(00)00080-5. Eur J Heart Fail. 2000. PMID: 10856736 Free article. Clinical Trial.
Is the prognosis of heart failure improving?
Khand A, Gemmel I, Clark AL, Cleland JG. Khand A, et al. Among authors: clark al. J Am Coll Cardiol. 2000 Dec;36(7):2284-6. doi: 10.1016/s0735-1097(00)00995-5. J Am Coll Cardiol. 2000. PMID: 11127474 Free article. No abstract available.
Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, V-MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failure.
Thackray SD, Witte KK, Khand A, Dunn A, Clark AL, Cleland JG. Thackray SD, et al. Among authors: clark al. Eur J Heart Fail. 2001 Jan;3(1):117-24. doi: 10.1016/s1388-9842(00)00145-8. Eur J Heart Fail. 2001. PMID: 11163746 Free article. Clinical Trial.
736 results